LA BioMed Receives Record-breaking Donation

Jones Joan

Board Member Joan Jones Pledges $3 million to Launch Institute’s Capital Campaign

LOS ANGELES – (May 6, 2015) – Los Angeles Biomedical Research Institute (LA BioMed) announced today that it is receiving its biggest donation ever – a $3 million contribution to launch its Capital Campaign – from one of its newest board members, Joan Hood Jones, the former mayor of Manhattan Beach and a former city councilmember.

LA BioMed Honors its Legends and Celebrates its Future

Invitation Legends EBlast

Three Distinguished Physician-Researchers to be Recognized May 7. Groundbreaking Ceremony Set for May 6.

LOS ANGELES – (April 28, 2015) – Los Angeles Biomedical Research Institute (LA BioMed) will honor its past by recognizing three distinguished physician-researchers as “Legends” on May 7, and it will celebrate its future with a groundbreaking ceremony May 6 for a campus transformation designed to foster a more collaborative research environment.

Wildside to the table: Las Candalistas

Spoon FA Print Ad

Celebrating fresh, garden to table entertaining. 

The Kids in Dependency System (K.I.D.S.) Clinic has been chosen as one of the top three 2015 charities to receive support from Las Candalistas, a local philanthropic organization that fundraises to support the health and well-being of children and the environment.  Please consider attending their “Wildside to the Table” event on Thursday, April 30 to support their efforts in assisting the K.I.D.S. Clinic.  Click here for more information.

More analysis from the women’s health initiative on hormones, breast cancer

Rowan T. Chlebowski, M.D., Ph.D.

Analysis of the longer-term influence of menopausal hormone therapy on breast cancer incidence in two Women’s Health Initiative (WHI) clinical trials suggests a pattern of changing influences over time on breast cancer, according to an article published online by JAMA Oncology.

Emergency departments improve readiness to care for children

Dr. Marianne Gausche-Hill

Pediatric emergency care coordinators in the nation’s emergency departments are strongly linked with improved readiness to care for children, according to a new study in . Nearly 50 percent of the nation’s emergency departments have a physician or nurse dedicated to address staff training, equipment availability and policies for the care of children—a three-fold increase since 2003. This is an important finding because the presence of a pediatric emergency care coordinator is strongly correlated with improved pediatric readiness, independent of other factors.

Leonard Nimoy Documentary Makers Enlist LA BioMed Researcher

Richard Casaburi, PhD, MD

Actor’s Daughter Seeking Expertise for Video to Help COPD Patients   

New Book Provides Workable Approaches for Combating Bullying

Rashmi Shetgiri, MD

LA BioMed Researcher Co-authors “Practical Strategies for Clinical Management of Bullying”

LOS ANGELES – “Practical Strategies for Clinical Management of Bullying,” a new book co-authored by Rashmi Shetgiri, MD, a Los Angeles Biomedical Research Institute (LA BioMed) lead researcher, provides the latest findings about bullying and workable approaches for combating this social epidemic.

LA BioMed Researcher, Dr. Rossiter to Study Pulmonary Rehab in Underserved COPD Patients

Harry Rossiter, PhD

ATS Foundation and Breathe California Award Grant to Harry Rossiter, PhD

LOS ANGELES – April 1, 2015 –The ATS Foundation and Breathe California of Los Angeles have awarded $80,000 to Harry Rossiter, PhD, a lead researcher at the Los Angeles Biomedical Research Institute (LA BioMed), to study the effectiveness of pulmonary rehabilitation in reducing chronic obstructive pulmonary disease (COPD) symptoms in an underserved population in Los Angeles.

Two Commonly Used Antibiotics Have Similar Cure Rates for Uncomplicated Skin Infections

Loren G. Miller, MD

NEJM Study is First to Compare Medications Prescribed for Cellulitis

LOS ANGELES – (March 18, 2015) – Two antibiotics frequently prescribed to treat serious skin infections – clindamycin and trimethoprim sulfamethoxazole (TMP-SMX) – had similar rates of nejm-logo1success in curing uncomplicated infections in outpatients, according to a study published today in the New England Journal of Medicine.